All Stories

  1. Lentiviral Gene Therapy for Cerebral Adrenoleukodystrophy

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, October 2024, New England Journal of Medicine (NEJM/MMS)

    Dr Satiro N De Oliveira

  2. Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment

    Article • Nature Communications, April 2024, Springer Science + Business Media

    Dr Satiro N De Oliveira

  3. Intensive care risk and long-term outcomes in pediatric allogeneic hematopoietic cell transplant recipients

    Article • Blood Advances, February 2024, American Society of Hematology

    Dr Satiro N De Oliveira

  4. Bone Marrow Failure Associated with Short Telomeres and Digenic Variants of Uncertain Significance in Telomere Biology Genes

    Article • Blood, November 2023, American Society of Hematology

    Dr Satiro N De Oliveira

  5. Mediport use as an acceptable standard for CAR T cell infusion

    Article • Frontiers in Immunology, October 2023, Frontiers

    Dr Satiro N De Oliveira

  6. Fluorinated Silane-Modified Filtroporation Devices Enable Gene Knockout in Human Hematopoietic Stem and Progenitor Cells

    Article • ACS Applied Materials & Interfaces, August 2023, American Chemical Society (ACS)

    Dr Satiro N De Oliveira

  7. Interim Results from an Ongoing Phase 1/2 Study of Lentiviral-mediated Ex-vivo Gene Therapy for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)

    Article • Blood, November 2022, American Society of Hematology

    Dr Satiro N De Oliveira

  8. Lentiviral Gene Therapy with Low Dose Conditioning for X-Linked SCID Results in Complete Immune Reconstitution and No Evidence of Clonal Expansion

    Article • Blood, November 2022, American Society of Hematology

    Dr Satiro N De Oliveira

  9. Long-Term Outcome of Gene Therapy for X-Linked Severe Combined Immunodeficiency (SCID-X1) Using an Enhancer-Deleted Self-Inactivating Gammaretroviral Vector

    Article • Blood, November 2022, American Society of Hematology

    Dr Satiro N De Oliveira

  10. Comparison of Outcomes in Patients with Cerebral Adrenoleukodystrophy (CALD) Receiving Elivaldogene Autotemcel (eli-cel; Lenti-D) Gene Therapy in Clinical Trials Versus Those Receiving Allogeneic Hematopoietic Stem Cell Transplant in a Contemporaneous ...

    Article • Transplantation and Cellular Therapy, March 2022, Elsevier

    Dr Satiro N De Oliveira

  11. Post-Transplantation Cyclophosphamide Is Associated with an Increase in Non-Cytomegalovirus Herpesvirus Infections in Patients with Acute Leukemia and Myelodysplastic Syndrome

    Article • Transplantation and Cellular Therapy, January 2022, Elsevier

    Dr Satiro N De Oliveira

  12. A Phase 1/2 Study of Lentiviral-Mediated Ex-Vivo Gene Therapy for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I): Interim Results

    Article • Blood, November 2021, American Society of Hematology

    Dr Satiro N De Oliveira

  13. Long-term outcomes after gene therapy for adenosine deaminase severe combined immune deficiency

    Article • Blood, October 2021, American Society of Hematology

    Dr Satiro N De Oliveira

  14. Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood ...

    Article • Haematologica, August 2021, Ferrata Storti Foundation (Haematologica)

    Hemant Murthy, Dr Satiro N De Oliveira

  15. Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, May 2021, New England Journal of Medicine (NEJM/MMS)

    Dr Satiro N De Oliveira

  16. Elivaldogene Autotemcel (eli-cel, Lenti-D) Gene Therapy for the Treatment of Cerebral Adrenoleukodystrophy: Updated Results from the Phase 2/3 ALD-102 Study and First Report on Safety Outcomes from the Phase 3 ALD-104 Study

    Article • Transplantation and Cellular Therapy, March 2021, Elsevier

    Dr Satiro N De Oliveira

  17. The Efficacy and Safety of Pharmacokinetics Guided Once-Daily Intravenous Busulfan in Pediatric Patients Receiving Hematopoietic Stem Cell Transplant

    Article • Transplantation and Cellular Therapy, March 2021, Elsevier

    Dr Satiro N De Oliveira

  18. A Phase 1/2 Study of Lentiviral-Mediated Ex-Vivo Gene Therapy for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I): Results from Phase 1

    Article • Blood, November 2020, American Society of Hematology

    Dr Satiro N De Oliveira

  19. First Report of Non-Genotoxic Conditioning with JSP191 (anti-CD117) and Hematopoietic Stem Cell Transplantation in a Newly Diagnosed Patient with Severe Combined Immune Deficiency

    Article • Blood, November 2020, American Society of Hematology

    Dr Satiro N De Oliveira

  20. AT1R Activating Autoantibodies in Hematopoietic Stem Cell Transplantation

    Article • Biology of Blood and Marrow Transplantation, November 2020, Elsevier

    Dr Satiro N De Oliveira

  21. Pediatric hematopoietic cell transplantation: Longitudinal trends in body mass index and outcomes

    Article • Pediatric Transplantation, September 2020, Wiley

    Dr Satiro N De Oliveira

  22. Acoustofluidic sonoporation for gene delivery to human hematopoietic stem and progenitor cells

    Article • Proceedings of the National Academy of Sciences, May 2020, Proceedings of the National Academy of Sciences

    Dr Satiro N De Oliveira

  23. Lenti-D Hematopoietic Stem Cell Gene Therapy Stabilizes Neurologic Function in Boys with Cerebral Adrenoleukodystrophy

    Article • Biology of Blood and Marrow Transplantation, March 2020, Elsevier

    Dr Satiro N De Oliveira

  24. Management Blueprint for Acquired Long QT Syndrome in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation

    Article • Biology of Blood and Marrow Transplantation, March 2020, Elsevier

    Dr Satiro N De Oliveira

  25. Safety of Autologous Hematopoietic Stem Cell Transplantation with Gene Addition Therapy for Transfusion-Dependent β-Thalassemia, Sickle Cell Disease, and Cerebral Adrenoleukodystrophy

    Article • Biology of Blood and Marrow Transplantation, March 2020, Elsevier

    Dr Satiro N De Oliveira

  26. Successful engraftment of haploidentical bone marrow with post‐transplantation cyclophosphamide in patients with aplastic anemia

    Article • Pediatric Transplantation, January 2020, Wiley

    Dr Satiro N De Oliveira

  27. Dissecting the Immune Cell Progeny of CAR-Expressing Hematopoietic Stem Cells in a Humanized Mouse Model

    Article • Blood, November 2019, American Society of Hematology

    Dr Satiro N De Oliveira

  28. Lentiviral Gene Therapy with Autologous Hematopoietic Stem and Progenitor Cells (HSPCs) for the Treatment of Severe Combined Immune Deficiency Due to Adenosine Deaminase Deficiency (ADA-SCID): Results in an Expanded Cohort

    Article • Blood, November 2019, American Society of Hematology

    Dr Satiro N De Oliveira

  29. Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for Cancer

    Article • Cell Stem Cell, October 2019, Elsevier

    Dr Satiro N De Oliveira

  30. Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood ...

    Article • Haematologica, September 2019, Ferrata Storti Foundation (Haematologica)

    Hemant Murthy, Dr Satiro N De Oliveira

  31. A Cetuximab-Mediated Suicide System in Chimeric Antigen Receptor–Modified Hematopoietic Stem Cells for Cancer Therapy

    Article • Human Gene Therapy, April 2019, Mary Ann Liebert Inc

    Dr Satiro N De Oliveira

  32. Updated Safety and Efficacy Outcomes from an Ongoing Phase 2/3 Trial of Lenti-D Autologous Hematopoietic Stem Cell Gene Therapy for the Treatment of Cerebral Adrenoleukodystrophy

    Article • Biology of Blood and Marrow Transplantation, March 2019, Elsevier

    Dr Satiro N De Oliveira

  33. Viral Infection Rates and Associated Serious Complications in Pediatric Umbilical Cord Blood Transplant Patients over the Last Decade

    Article • Biology of Blood and Marrow Transplantation, March 2019, Elsevier

    Dr Satiro N De Oliveira

  34. Engineering Precision Medicine to Increase Graft-Versus-Lymphoma Activity: Hematopoietic Stem Cells Modified with Chimeric Antigen Receptors

    Article • Blood, November 2018, American Society of Hematology

    Dr Satiro N De Oliveira

  35. Activity of Anti-CD19 Chimeric Antigen Receptor T Cells Against B Cell Lymphoma Is Enhanced by Antibody-Targeted Interferon-Alpha

    Article • Journal of Interferon & Cytokine Research, June 2018, Mary Ann Liebert Inc

    Dr Satiro N De Oliveira

  36. Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM Syndrome

    Article • Cell Reports, May 2018, Elsevier

    Dr Satiro N De Oliveira

  37. Lenti-D Hematopoietic Stem Cell Gene Therapy to Arrest Progression of Cerebral Adrenoleukodystrophy: Interim Results of an International Phase 2/3 Trial

    Article • Biology of Blood and Marrow Transplantation, March 2018, Elsevier

    Dr Satiro N De Oliveira

  38. Isolated Testicular Recurrence of AML in Patients With Chronic GVHD >1 Year Following Allogeneic Stem Cell Transplant

    Article • Journal of Pediatric Hematology/Oncology, November 2017, Wolters Kluwer Health

    Dr Satiro N De Oliveira

  39. Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, October 2017, New England Journal of Medicine (NEJM/MMS)

    Dr Satiro N De Oliveira

  40. Umbilical Cord Blood Transplantation in Children with Acute Leukemia: Impact of Conditioning on Transplantation Outcomes

    Article • Biology of Blood and Marrow Transplantation, October 2017, Elsevier

    Dr Satiro N De Oliveira

  41. Use of Rapamycin in a Patient With Juvenile Myelomonocytic Leukemia: A Case Report

    Article • Journal of Investigative Medicine High Impact Case Reports, July 2017, SAGE Publications

    Dr Satiro N De Oliveira

  42. Clinical efficacy of gene-modified stem cells in adenosine deaminase–deficient immunodeficiency

    Article • Journal of Clinical Investigation, March 2017, American Society for Clinical Investigation

    Dr Satiro N De Oliveira

  43. Pre-clinical development of gene modification of haematopoietic stem cells with chimeric antigen receptors for cancer immunotherapy

    Article • Human Vaccines & Immunotherapeutics, January 2017, Taylor & Francis

    Dr Satiro N De Oliveira

  44. Anti-CD19 Chimeric Antigen Receptor in Hematopoietic Stem Cells Controlled By the Suicide Gene HSV-sr39TK for Immunotherapy of B-Lineage Malignancies

    Article • Blood, December 2016, American Society of Hematology

    Dr Satiro N De Oliveira

  45. Gene Modification of Human Hematopoietic Stem Cells with Suicide Genes As a Safety Control

    Article • Blood, December 2016, American Society of Hematology

    Dr Satiro N De Oliveira

  46. second HSCT for relapsed APML

    Article • Pediatric Transplantation, February 2016, Wiley

    Dr Satiro N De Oliveira

  47. In Vitro Generation of Human NK Cells Expressing Chimeric Antigen Receptor Through Differentiation of Gene-Modified Hematopoietic Stem Cells

    Article • January 2016, Springer Science + Business Media

    Dr Satiro N De Oliveira

  48. False-positive magnetic resonance imaging findings in follow-up of pediatric patients with tumors of the central nervous system

    Article • SAGE Open Medical Case Reports, January 2016, SAGE Publications

    Dr Satiro N De Oliveira

  49. Pre-Clinical Development of Gene Modification of Hematopoietic Stem Cells with Chimeric Antigen Receptors for Cancer Immunotherapy

    Article • Blood, December 2015, American Society of Hematology

    Dr Satiro N De Oliveira

  50. Development of Optimized Protocol for Generation of NK Cells Expressing Chimeric Antigen Receptors from Hematopoietic Stem Cells for Cancer Immunotherapy

    Article • Blood, December 2015, American Society of Hematology

    Dr Satiro N De Oliveira

  51. 30. Phase II Clinical Trial of Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency (ADA-SCID) Using a γ-Retroviral Vector

    Article • Molecular Therapy, May 2015, Elsevier

    Dr Satiro N De Oliveira

  52. Autologous Transplant/Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency

    Article • Biology of Blood and Marrow Transplantation, February 2015, Elsevier

    Dr Satiro N De Oliveira

  53. Second-Generation Chimeric Antigen Receptors Successfully Modify Hematopoietic Stem Cells for Immunotherapy of B-Lineage Malignancies

    Article • Blood, December 2014, American Society of Hematology

    Dr Satiro N De Oliveira

  54. Systematic Comparison of the EF-1 Alpha Short (EFS) and Viral Promoters for Gene Modification of Human Primary Cells for Clinical Applications

    Article • Blood, December 2014, American Society of Hematology

    Dr Satiro N De Oliveira

  55. A Modified γ-Retrovirus Vector for X-Linked Severe Combined Immunodeficiency

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, October 2014, New England Journal of Medicine (NEJM/MMS)

    Dr Satiro N De Oliveira

  56. Abstract B70: Modification of hematopoietic stem cells with CD19-specific chimeric antigen receptors as a novel approach for cancer immunotherapy

    Article • Cancer Research, October 2014, American Association for Cancer Research (AACR)

    Dr Satiro N De Oliveira

  57. Gene Therapy: Charting a Future Course—Summary of a National Institutes of Health Workshop, April 12, 2013

    Article • Human Gene Therapy, June 2014, Mary Ann Liebert Inc

    Dr Satiro N De Oliveira, Head of Viral Platforms Thomas Weber

  58. Human Lymphoid Development in the Absence of Common  -Chain Receptor Signaling

    Article • The Journal of Immunology, April 2014, The American Association of Immunologists

    Dr Satiro N De Oliveira

  59. Gene-modified hematopoietic stem cells for cancer immunotherapy

    Article • Human Vaccines & Immunotherapeutics, January 2014, Taylor & Francis

    Dr Satiro N De Oliveira

  60. Hematopoietic stem cells for cancer immunotherapy

    Article • Immunological Reviews, December 2013, Wiley

    Dr Satiro N De Oliveira

  61. Anti-CD19 Chimeric Antigen Receptor Controlled By The Suicide Gene HSVsr39TK In Hematopoietic Stem Cells For Immunotherapy Of B-Lineage Malignancies

    Article • Blood, November 2013, American Society of Hematology

    Dr Satiro N De Oliveira

  62. A Pre-Clinical Model Of Hematopoietic Stem Cell Based Immunotherapy For Cancer Utilizing The NY-ESO-1 T-Cell Receptor and sr39TK PET Reporter / Suicide Gene

    Article • Blood, November 2013, American Society of Hematology

    Dr Satiro N De Oliveira

  63. Modification of Hematopoietic Stem/Progenitor Cells with CD19-Specific Chimeric Antigen Receptors as a Novel Approach for Cancer Immunotherapy

    Article • Human Gene Therapy, October 2013, Mary Ann Liebert Inc

    Dr Satiro N De Oliveira

  64. β-globin gene transfer to human bone marrow for sickle cell disease

    Article • Journal of Clinical Investigation, July 2013, American Society for Clinical Investigation

    Dr Satiro N De Oliveira

  65. Stem Cell Transplantation in Primary Myelofibrosis of Childhood

    Article • Journal of Pediatric Hematology/Oncology, April 2013, Wolters Kluwer Health

    Dr Satiro N De Oliveira

  66. Same Sibling Marrow Following Cord Allogeneic Transplantation as Therapy for Second Relapse APL: A Pediatric Case Report

    Article • Biology of Blood and Marrow Transplantation, February 2013, Elsevier

    Dr Satiro N De Oliveira

  67. A CD19/Fc fusion protein for detection of anti-CD19 chimeric antigen receptors

    Article • Journal of Translational Medicine, January 2013, Springer Science + Business Media

    Dr Satiro N De Oliveira

  68. Gene Transfer to Hematopoietic Stem/Progenitor Cells As a Novel Approach for Immunotherapy Against B-Lineage Malignancies: In Vivo Xenograft Model,

    Article • Blood, November 2011, American Society of Hematology

    Dr Satiro N De Oliveira

  69. Prognostic significance ofWT1 gene expression in pediatric acute myeloid leukemia

    Article • Pediatric Blood & Cancer, January 2007, Wiley

    Dr Satiro N De Oliveira

  70. A novel translocation (x;4)(p22.1;q32) in a child with malignant Schwannoma

    Article • Journal of Clinical Oncology, July 2004, American Society of Clinical Oncology (ASCO)

    Dr Satiro N De Oliveira

  71. Radioterapia em adenocarcinoma de pâncreas

    Article • Revista da Associação Médica Brasileira, June 2002, Elsevier

    Dr Satiro N De Oliveira

  72. AVALIAÇÃO EPIDEMIOLÓGICA DA HANSENÍASE E DOS SERVIÇOS RESPONSÁVEIS POR SEU ATENDIMENTO EM RIBEIRÃO PRETO - SP NO ANO DE 1992

    Article • Medicina (Ribeirão Preto), March 1996, Universidade de Sao Paulo Sistema Integrado de Bibliotecas - SIBiUSP

    Dr Satiro N De Oliveira